Endothelium-dependent relaxation to alpha-methyl-5-hydroxytryptamine in isolated horse coronary arteries.

This research investigates the role of a receptor subtype of 5-hydroxytryptamine (5-HT), a molecule involved in coronary vasospasms, in the relaxation of horse coronary arteries, considering specific factors released by endothelial cells. The study suggests that the activation of this receptor subtype triggers mainly Nitric Oxide (NO)-based relaxation in horse coronary arteries.

Research Methodology

• The research used a compound called alpha-methyl-5-HT to study the subtype of 5-HT receptor located on endothelial cells in horse coronary arteries. This compound has been shown to cause relaxation in these arteries when endothelium, the innermost layer of the arteries, is present.
• Horse coronary arteries were obtained and cleaned, with small sections created for the experiments. These sections were placed in a controlled environment for measuring isometric tension, which partially contracted with a specific compound, ON011113. The effects of alpha-methyl-5-HT were then observed.
• In separate experiments, denuded (i.e., without endothelium) and intact coronary arteries were used to investigate the release and effect of endothelium-derived relaxing factors (EDRFs) in response to alpha-methyl-5-HT treatment.
• The experiment also introduced various antagonists and inhibitors, which can interfere with or blunt biological responses, to examine their impact on the EDRF-induced relaxation.

Key Findings of the Study

• Alpha-methyl-5-HT caused dose-dependent relaxation in horse coronary arteries with intact endothelium but not in arteries devoid of endothelium.
• The relaxing effect was not inhibited by certain compounds (prazosin, atropine, MDL72222), indicating their little to no impact on this type of relaxation.
• However, other substances (methysergide, ketanserin, mianserin, methiothepin) were found to inhibit relaxation, pointing to their potential roles in interfering with this process.
• Two more substances, Methylene blue and L-nitro-arginine, significantly inhibited the relaxation, implying they could be affecting the release or action of EDRFs.
• Finally, the experiment supported the claim that a specific subtype of the 5-HT receptor is present on the cells lining the horse coronary arteries which, when stimulated, leads to the production of EDRFs, mainly composed of Nitric Oxide.